HCM
TECH icon

Hilton Capital Management’s Bio-Techne TECH Stock Holding History

Hilton Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78M Sell
53,568
-5,720
-10% -$309K 0.26% 98
2026
Q1 		$3.1M Buy
59,288
+7,905
+15% +$474K 0.23% 100
2025
Q4 		$3.02M Buy
51,383
+4,625
+10% +$281K 0.23% 98
2025
Q3 		$2.6M Buy
46,758
+2,478
+6% +$133K 0.21% 94
2025
Q2 		$2.28M Buy
44,280
+4,094
+10% +$206K 0.18% 101
2025
Q1 		$2.36M Buy
40,186
+9,772
+32% +$662K 0.2% 84
2024
Q4 		$2.19M Buy
30,414
+5,745
+23% +$422K 0.19% 88
2024
Q3 		$1.97M Sell
24,669
-1,283
-5% -$96.4K 0.15% 86
2024
Q2 		$1.86M Buy
25,952
+4,427
+21% +$326K 0.16% 91
2024
Q1 		$1.52M Buy
21,525
+12,110
+129% +$867K 0.14% 111
2023
Q4 		$726K Buy
9,415
+6,345
+207% +$418K 0.08% 91
2023
Q3 		$209K Sell
3,070
-33
-1% -$2.61K 0.03% 102
2023
Q2 		$253K Buy
3,103
+607
+24% +$48.8K 0.03% 88
2023
Q1 		$207K Buy
+2,496
New +$192K 0.03% 104

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hilton Capital Management's TECH Position: Q2 2026 in Review

Hilton Capital Management reduced its Bio-Techne (TECH) stake by 9.6% in Q2 2026, selling an estimated $309K and leaving 53,568 shares worth $3.78M. The position accounts for 0.26% of the portfolio, ranked #98.

Hilton Capital Management first reported a position in TECH in Q1 2023 and has held it in 14 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Hilton Capital Management held 53,568 shares of Bio-Techne worth $3.78M as of Q2 2026.
  • Hilton Capital Management sold 5,720 Bio-Techne shares in Q2 2026, an estimated $309K.
  • Bio-Techne made up 0.26% of Hilton Capital Management's portfolio in Q2 2026, its #98 holding.
  • Hilton Capital Management first reported a position in Bio-Techne in Q1 2023 and has held it in 14 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Hilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.